Connect with us

Hi, what are you looking for?

Alive Business PlanAlive Business Plan

Stock

Novo shares hits 9-month low as 2025 guidance underwhelms

By Danilo Masoni

MILAN (Reuters) – Danish drugmaker Novo Nordisk (NYSE:NVO)’s shares hit an over 9-month low on Thursday after surging more than 8% the previous day, as underwhelming guidance for next year overshadowed strong sales growth for its popular Wegovy weight-loss drug.

The two-day move saw Europe’s biggest company by market cap trade in a wide 14-percentage-point range from low to high. By 1018 GMT, the stock was down 3% in Copenhagen (OMXC20) after earlier falling 5.5% to its lowest since January.

In an analyst call on Wednesday, following a quarterly release that eased concerns that demand for Wegowy was slowing, Novo’s finance chief Karsten Munk Knudsen said sales growth next year could be in the high percentage teens.

Barclays (LON:BARC) said commentary on 2025 weighed on the shares.

“We had a call back with IR and the moving parts seem to indicate (at least what we know now) a midpoint for FY25 top line a touch lower than current company consensus,” Emily Field, analyst at the UK bank, wrote in a note, affirming her overweight rating on the stock.

The company will formally guide for 2025 in February.

Gilles Guibout, head of European equity strategies at AXA Investment Managers in Paris, said the sharp moves in Novo’s shares were probably due to hedge fund action.

“Novo Nordisk is a widely held stock. Its market has significant potential. However, it’s easier to find sellers than buyers for the stock, as everyone already holds plenty of it,” he said.

“It’s a stock that needs to be normalised. At the beginning of the year, there was too much hype around it,” he added.

Novo Nordisk shares are up around 4% so far this year, but they have fallen almost 30% from the record high set in June.

The stock trades at a 27 times its expected earnings, a 22% premium to its 20-year average valuation, according to LSEG Datastream data. It is worth around $470 billion.

This post appeared first on investing.com
Become a VIP member by signing up for our newsletter. Enjoy exclusive content, early access to sales, and special offers just for you! As a VIP, you'll receive personalized updates, loyalty rewards, and invitations to private events. Elevate your experience and join our exclusive community today!

    By opting in you agree to receive emails from us and our affiliates. Your information is secure and your privacy is protected.

    You May Also Like

    Latest News

    The Gateway Pundit, a far-right website, published a note from its editor on Saturday acknowledging that two election workers in Georgia did not engage...

    Latest News

    New majorities in Congress, particularly when the incoming party has a new leader, offer the rare chance for the institution to take a breath...

    Investing

    JAKARTA (Reuters) -Indonesia has asked Alphabet (NASDAQ:GOOGL)’s Google and Apple (NASDAQ:AAPL) to block Chinese fast fashion e-commerce firm Temu in their application stores in...

    Latest News

    Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...



    Disclaimer: alivebusinessplan.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.


    Copyright © 2024 alivebusinessplan.com